Anaptysbio (ANAB) Interest Expenses (2016 - 2019)
Anaptysbio (ANAB) reported Interest Expenses of $200000.0 for Q4 2019, down 45.21% on a YoY basis from $365000.0 in Q4 2018, and down 16.67% quarter-over-quarter from $240000.0 in Q3 2019.
Anaptysbio (ANAB) Interest Expenses (2016 - 2019) Analysis & Trends
Anaptysbio has reported Interest Expenses for 4 years, with the latest figure at $200000.0 in Q4 2019.
- For the quarter ending Q4 2019, Interest Expenses fell 45.21% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2020 stood at $200000.0 (down 83.42% YoY), and the FY2019 full-year result was $1.0 million, down 36.99% from the prior year.
- Interest Expenses for Q4 2019 stood at $200000.0, down from $240000.0 in the prior quarter.
- The five-year high for Interest Expenses was $456000.0 in Q4 2017, with the low at $111000.0 in Q4 2016.
- Historically, Interest Expenses has averaged $307875.0 across 4 years, with a median of $342500.0 in 2018.
- Annual changes were most pronounced in 2017 — Interest Expenses surged 310.81% — and 2019, when it sank 45.21%.
- Anaptysbio's Interest Expenses stood at $111000.0 in 2016, then surged by 310.81% to $456000.0 in 2017, then decreased by 19.96% to $365000.0 in 2018, then sank by 45.21% to $200000.0 in 2019.
- The last three Interest Expenses figures came in at $200000.0 (Q4 2019), $240000.0 (Q3 2019), and $281000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 240,000.00 |
| Sep 30, 2019 | 240,000.00 |
| Jun 30, 2019 | 281,000.00 |
| Jun 30, 2019 | 281,000.00 |
| Mar 31, 2019 | 320,000.00 |
| Mar 31, 2019 | 320,000.00 |
| Dec 31, 2018 | 365,000.00 |
| Dec 31, 2018 | 365,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 436,000.00 |
| Jun 30, 2018 | 436,000.00 |
| Mar 31, 2018 | 451,000.00 |
| Mar 31, 2018 | 451,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 452,000.00 |
| Sep 30, 2017 | 452,000.00 |